{"id":2480308,"date":"2025-12-02T12:35:11","date_gmt":"2025-12-02T12:35:11","guid":{"rendered":"https:\/\/prgn.com\/?page_id=2480308"},"modified":"2026-05-13T14:39:58","modified_gmt":"2026-05-13T14:39:58","slug":"pharmaceuticals","status":"publish","type":"page","link":"https:\/\/prgn.com\/es_es\/sectors\/pharmaceuticals\/","title":{"rendered":"Industria farmac\u00e9utica"},"content":{"rendered":"
Sectores<\/a><\/div>

Industria farmac\u00e9utica<\/p>\n<\/div><\/div><\/div><\/div><\/div>

The global pharmaceutical industry is in strong growth mode yet facing an increasingly diverse range of challenges. Overall, demand remains strong, especially in sectors such as specialty drugs and biologics, however a combination of rising costs, supplychain pressures and regulatory scrutiny weigh heavily. <\/p>\n

A specific and unpredictable challenge facing the sector is the new importtariff regime aggressively introduced by President Trump: proposed tariffs on drug imports risk increasing prices and disrupting global supply chains while undermining foreign investment. <\/p>\n

At the same time, the industry is seeing renewed innovation in treatments and operations expansion, with companies seeking to offset tariff risks and regulatory pressures. <\/p>\n<\/div><\/div><\/div><\/div>

Trusted by the organisations shaping their industries<\/h2><\/div><\/div>

We work, and have worked, with some of the world\u2019s foremost pharmaceutical brands, delivering memorable campaigns and tangible results. Our unified approach is trusted by an industry for which trust is everything.<\/p>\n<\/div><\/div><\/div>

<\/span><\/div>
<\/span><\/div><\/div>
<\/span><\/div>
<\/span><\/div><\/div>
<\/span><\/div>
<\/span><\/div><\/div><\/div><\/div>

Connect with our Pharmaceuticals PR specialists<\/h2><\/div><\/div><\/div><\/div>
\"Jenny<\/div>

Jenny Ousbey<\/h4>

OVID Health<\/p>

London, UK<\/p>\n<\/div><\/div><\/div><\/div>

\"Robert<\/div>

Robert Bauer<\/h4>

accelent communications<\/p>

Vienna, Austria<\/p>\n<\/div><\/div><\/div><\/div>

\"Alexandra<\/div>

Alexandra Dinita<\/h4>

Free Communication<\/p>

Bucharest, Romania<\/p>\n<\/div><\/div><\/div><\/div>

\"Fr\u00e9d\u00e9ric<\/div>

Fr\u00e9d\u00e9ric Fran\u00e7ois<\/h4>

Two cents<\/p>

Brussels, Belgium<\/p>\n<\/div><\/div><\/div><\/div>

\"Shawn<\/div>

Shawn Jiang Xiaofeng<\/h4>

China Advocate<\/p>

Beijing, China<\/p>\n<\/div><\/div><\/div><\/div>

\"Ieva<\/div>

Ieva Naujalyte<\/h4>

Adverum<\/p>

Vilnius, Lithuania<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div>

Communications opportunities<\/h4>

Within this fast-moving sector, communications strategy can help pharmaceutical organizations to both grow market share and navigate industry challenges. Clear, science-driven storytelling can help companies to stand out by highlighting innovation, clinical breakthroughs, patient outcomes and safety standards while consistent thought leadership in compliance, supply-chain resilience and public health initiatives can help to boost credibility.<\/p>\n

For pharma firms, multi-channel digital engagement has the potential to drive education, advocacy and patient outreach; this strategy can also build transparency around key issues such as pricing, access and sustainability. Integrated communications campaigns can also help companies address misinformation and highlight competitive advantages, ultimately supporting market growth and stakeholder confidence.<\/p>\n<\/div><\/div><\/div><\/div>

PRGN: your partner<\/h4>

PRGN is in a unique position to help pharma organizations to take advantage of these opportunities. Through coordinated, multi-market campaigns combining global reach with local insight, we ensure consistent messaging while tailoring content to suit regional regulatory environments and local media landscapes. <\/p>\n

Our members offer the full suite of services including media relations, thought leadership, crisis management and stakeholder engagement across all channels, helping organizations to amplify the positives (innovation, patient outcomes) and mitigate against risks (misinformation, pricing scrutiny, supply chain concerns). <\/p>\n<\/div><\/div><\/div><\/div><\/div>

Get in touch with a PRGN agency<\/h4><\/div><\/div><\/div>